Microbiological justification for a combined approach to antimicrobial therapy for periodontal infection associated with periodontopathogenic anaerobes
https://doi.org/10.33925/1683-3759-2024-938
Abstract
Relevance. Despite the broader indications for the use of fluoroquinolones and imidazoles in dentistry, particularly in the complex treatment of periodontitis, the sensitivity of the principal causative agents of periodontitis, specifically anaerobic periodontopathogens, remains inadequately studied.
Purpose. Is to justify the use of a combination of fluoroquinolone (ciprofloxacin) and nitroimidazole (tinidazole) chemotherapeutic agents using modern in vitro culture monitoring methods. To provide a rationale for the use of a combination of chemotherapeutic agents from the fluoroquinolone group (ciprofloxacin) and nitroimidazoles (tinidazole) utilising contemporary in vitro culture monitoring methods.
Materials and methods. The study employed the method of automatic programmable bacterial cultivation in the "RTS-1" bioreactor (Biosan, Latvia) in vitro. The bacterial strains examined included S. consellatus, P. gingivalis and F. nucleatum.
Results. The experiments demonstrated that the combined application of drugs from the fluoroquinolone and nitroimidazole groups (using the antibacterial complex Cifran ® CT) during the cultivation of anaerobic cultures resulted in the inhibition of bacterial population growth and division at a concentration of 25/250 µg/ml, with complete absence of bacterial development. Statistically significant inhibition of growth was observed at concentrations of 6.25/625 and 12.5/500 µg/ml.
Conclusion. The use of automatic programmable cultivation methods for microbial populations of anaerobic periodontopathogenic bacteria, followed by growth curve analysis, demonstrated the superiority of the combined form of ciprofloxacin and tinidazole over the beta-lactam antibiotic amoxicillin with clavulanate sodium.
Keywords
About the Authors
N. N. NuruevRussian Federation
Nadir N. Nuruev, DMD, Senior Laboratory Technician, Department of General and Surgical Dentistry
Moscow
M. S. Podporin
Russian Federation
Mikhail S. Podporin, DMD, PhD, Senior Lecturer, Department of the Microbiology, Virology, Immunology, V. I. Pokrovsky Scientific and Educational Institute of Fundamental Medicine
Moscow
T. V. Tsareva
Russian Federation
Tatyana V. Tsareva, DMD, PhD, Associate Professor, Department of the Microbiology, Virology, Immunology, V. I. Pokrovsky Scientific and Educational Institute of Fundamental Medicine
Moscow
R. V. Ushakov
Russian Federation
Rafael V. Ushakov, DMD, PhD, DSc, Professor, Head of the Department of General and Surgical Dentistry
Moscow
References
1. Orekhova LYu, Loboda ES, Kosova EV, Vashneva VYu, Petrov AA. Topical antibiotic therapy in periodontology. Parodontologiya. 2020;25(3):217-223 (In Russ.). doi: 10.33925/1683-3759-2020-25-3-217-223
2. Ushakov RV, Tsarev VN, Robustova TG, Ippolytov EV, Labazanov AA. Justification of algorithms of antimicrobial chemotherapy in the complex treatment of phlegmon head and neck. Clinical Dentistry (In Russ.). 2021;24(3):70-76 (In Russ.). doi: 10.37988/1811-153X_2021_3_69
3. Abe FC, Kodaira K, Motta CCB, Barberato-Filho S, Silva MT, Guimarães CC, et al. Antimicrobial resistance of microorganisms present in periodontal diseases: A systematic review and metaanalysis. Front Microbiol. 2022;13:961-986. doi: 10.3389/fmicb.2022.961986.
4. Sagina OV, Zabaluyeva EY, Zoryan EV, Atrushkevich VG. Ways to improve dental care with regard to the complex treatment for diseases of periodontal tissues. 2011;(2):153-154 (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=21306860
5. Makeeva IM, Daurova FYu, Biakova SF, Ippolitov EV, Gostev MS, Polikushina AO, et al. Sensitivity of microbial associations of periodontal lesions to antibacterial agents. Stomatology. 2016;95(3):26 30 (In Russ.). doi:10.17116/stomat201695326-30
6. Rams TE, Sautter JD, van Winkelhoff AJ. Comparative In Vitro Resistance of Human Periodontal Bacterial Pathogens to Tinidazole and Four Other Antibiotics. Antibiotics (Basel). 2020;7;9(2):68. doi: 10.3390/antibiotics9020068.
7. Jepsen K, Falk W, Brune F, Fimmers R, Jepsen S, Bekeredjian-Ding I. Prevalence and antibiotic susceptibility trends of periodontal pathogens in the subgingival microbiota of German periodontitis patients: A retrospective surveillance study. J Clin Periodontol. 2021;48(9):1216-1227. doi: 10.1111/jcpe.13468
8. Kovalevsky AM, Ushakova AV, Kovalevsky VA, Prozerina EYu. Bacterial biofilm of periodontal pockets: rethinking the experience of periodontology. Periodontology. 2018;23(2):18-21 (In Russ.). doi: 10.25636/PMP.1.2018.2.3
9. Tsarev VN, Ippolitov EV, Nikolaeva EN. Prevalence of genetic markers of resistance to antibiotics in biofilm-forming strains of obligate and elective anaerobes. Journal of Microbiology, Epidemiology and Immunobiology. 2017;(2):74-80 (In Russ.). Available from: https://elibrary.ru/item.asp?id=37330862
10. Ardila CM, Bedoya-García JA. Antimicrobial resistance of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in periodontitis patients. J Glob Antimicrob Resist. 2020;22:215-218. doi: 10.1016/j.jgar.2020.02.024
11. Ansiliero R, Gelinski JMLN, Samistraro QL, Baratto CM, Almeida CA, Locatelli C. Pathogenic Microbial Profile and Antibiotic Resistance Associated with Periodontitis. Indian J Microbiol. 2021;61(1):55-65. doi: 10.1007/s12088-020-00914-2
12. Iwahara K, Kuriyama T, Shimura S, Williams DW, Yanagisawa M, Nakagawa K, et al. Detection of cfxA and cfxA2, the beta-lactamase genes of Prevotella spp., in clinical samples from dentoalveolar infection by realtime PCR. J Clin Microbiol. 2006;44(1):172-6. doi: 10.1128/JCM.44.1.172-176.2006
13. Arutyunyan AA, Tsareva TV, Ippolitov EV, Sarkisyan M, Ponomareva AG. Prevalence of antibiotic resistance among bacterial strains isolated in chronic periodontitis and in healthy people. Russian Journal of Stomatology. 2023;16(1):19–23 (In Russ.). doi: 10.17116/rosstomat20231601119]
14. Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8:76. doi: 10.1186/s13756-019-0533-3
15. Ushakov RV, Nuruev NN, Ushakova TV, Karpova VM, Arutyunjan AA, Labazanov AA, et al. Combined antimicrobial chemotherapy (fluoroquinolones and imidazoles) in the complex treatment of inflammatory diseases of the periodontal. Clinical Dentistry (Russia). 2021;1(97):60-65 (In Russ.). doi: 10.37988/1811-153X_2021_1_6
16. Fuchs G, Kroeger A. Growth and nutrition. In: Biology of the Prokaryotes Lengeler JW, Drews G, Scglegel HG, editors. 1998: 117-145. ISBN 9785030037066. doi: 10.1002/9781444313314.ch6
17. Romo SA, Martinez-Morales F, Aragon-Martinez OH. Do fluoroquinolone agents produce therapeutic benefits or harmful effects in patients with periodontitis? A systematic review and meta-analysis. Dent Med Probl. 2021;58(2):253-266. doi: 10.17219/dmp/133512
18. Slazhneva ES, Atrushkevich VG, Orekhova LYu, Rumyantsev KA, Loboda ES, Zajceva OS.Comparative evaluation of changes in the periodontal microbiome in patients with chronic generalized periodontitis after Vector-therapy. Parodontologiya. 2020;25(3):190-200 (In Russ.). doi: 10.33925/1683-3759-2020-25-3-190-200
19. Ilyin VK, Rykova EN, Antropova EN, Solovieva ZO, Skedina MA, Kovaleva АА, et al. Status of the parodontium tissues in the conditions of long-term isolation inside an air-tight module. Aviakosmicheskaya i Ekologicheskaya Meditsina (Russia). 2021:55(5):19-24 (In Russ.). doi: 10.21687/0233-528X-2021-55-5-19-24
Review
For citations:
Nuruev NN, Podporin MS, Tsareva TV, Ushakov RV. Microbiological justification for a combined approach to antimicrobial therapy for periodontal infection associated with periodontopathogenic anaerobes. Parodontologiya. 2024;29(2):168-177. (In Russ.) https://doi.org/10.33925/1683-3759-2024-938